The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
New research reveals high rates of loss to follow-up among adolescents, with rates among those acquiring the infection in their teens nearly three times that of those infected perinatally.
Long-lasting antiretroviral drugs injected monthly present a ‘remarkable milestone’ in treatment options for people living with HIV
Without urgent action, HIV drug resistance is set to derail the HIV response and presents a significant threat to public health, the World Health Organization (WHO) warns today.
Key HIV drugs added to the list of medicines critical to public health, including tenofovir for HIV prevention, and dolutegravir.
‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.
With 17 million people now accessing antiretroviral treatment worldwide, HIV drug resistance has the potential to unravel progress towards the Fast-Track target of ending AIDS by 2030.
A new pill technology has the potential to simplify HIV treatment and curb the rise of drug-resistant HIV.
Rollout of antiretroviral therapy (ART) in low and middle income countries has averted over 850,000 cases of HIV-related opportunistic infections at a saving of at least $47 million per year.
Resistance to the commonly prescribed antiretroviral drug tenofovir is ‘surprisingly common’, according to findings published in the Lancet Infectious Diseases last week.
World Health Organisation releases new guidelines recommending all people living with HIV receive antiretroviral treatment, regardless of CD4 count.